Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lagricel Ofteno for Mild to Moderate Dry Eye
NCT04704531Phase 2Completed
- Sponsor
- Laboratorios Sophia
- Start
- Jan 2022
- Primary completion
- Jun 2022
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lagricel ofteno in dry eye syndrome (DED), sponsored by Laboratorios Sophia. Started Jan 2022; status: completed.
02
Drugs
lagricel ofteno
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT04704531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04704531.